Drug Stocks and the Health Insurance Bill
The health insurance bill signed into law this week should be a net positive for drug stocks and health care ETFs. While the bill does levy about $80 billion in various fees on the major pharmaceutical players over the next several years, it should also stoke sales by expanding drug insurance coverage as an additional 32 million Americans add health insurance.